Patent · US Active

Treatment of intrahepatic cholestatic diseases

US11406611B2 · kind B2 · utility

0Cited by
19References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 3, 2020
Grant dateAug 9, 2022
Priority date—
Expiry dateOct 8, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P1/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Treatment of intrahepatic cholestatic diseases by therapy with MBX-8025 or an MBX-8025 salt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.